title: Effects of octreotide in chronically mild stressed rats: possible role of immune and oxidative stress pathways.
abstract: Impairment of neuroendocrine, immune and antioxidant defenses contribute to pathophysiology of stress-induced depression. Somatostatin executes diverse regulatory effects on endocrine, exocrine and neural functions; however, the possibility that octreotide, a synthetic somatostatin analogue might mitigate stress-induced depression remains elusive. Hence, the current study aimed to explore the immunomodulatory and antioxidant effects of octreotide in a model of chronic mild stress (CMS). This paradigm was performed by exposing rats to a combination of mild unpredictable stressors for 21 days. Fifty male Wistar rats were divided into five groups; (1) control receiving saline, (2) octreotide given to normal unstressed animals. The remaining three groups were subjected to (3) CMS alone or in combination with octreotide (4) 50 μg/kg or (5) 90 μg/kg. Octreotide increased sucrose preference index and attenuated CMS-induced increases in plasma adrenocorticotrophic hormone and corticosterone levels. In addition, octreotide decreased plasma tumor necrosis factor-alpha concentration. Moreover, it prevented CMS-induced oxidative damage by enhancing the antioxidant defenses superoxide dismutase, glutathione reductase and glutathione in the hippocampus. Furthermore, octreotide normalized the elevated malondialdehyde and lactate dehydrogenase levels in the hippocampus. These results demonstrate a possible antidepressant-like activity of octreotide in CMS due to its antioxidant/antiinflammatory aptitude.
authors: Biochemistry Department, Faculty of Pharmacy, Misr International University, Cairo, Egypt.
authors: Mona F
authors: MF
authors: Schaalan
authors: Noha N
authors: NN
authors: Nassar
references: J Clin Neurosci. 2008 Jul;15(7):784-90
references: 18407497
references: Exp Toxicol Pathol. 2010 May;62(3):235-41
references: 19427178
references: J Neurosci Res. 2010 Aug 15;88(11):2524-33
references: 20623537
references: Psychoneuroendocrinology. 2010 Nov;35(10):1553-64
references: 20594764
references: CNS Neurol Disord Drug Targets. 2010 Aug;9(4):439-54
references: 20522012
references: Arch Gen Psychiatry. 1994 Jan;51(1):8-19
references: 8279933
references: J Appl Physiol (1985). 2010 May;108(5):1041-51
references: 20167667
references: Pharmacol Ther. 2007 Nov;116(2):322-41
references: 17719647
references: J Endocrinol Invest. 2009 Feb;32(2):123-9
references: 19411809
references: Chem Biol Interact. 2010 Jul 30;186(2):200-10
references: 20307516
references: J Biol Chem. 1951 Nov;193(1):265-75
references: 14907713
references: Methods Enzymol. 1981;77:373-82
references: 7329314
references: Psychopharmacology (Berl). 1997 Dec;134(4):319-29
references: 9452163
references: J Affect Disord. 1995 Aug 18;34(4):301-9
references: 8550956
references: Eur J Neurosci. 2001 Mar;13(6):1155-65
references: 11285013
references: Life Sci. 2008 Apr 23;82(17-18):934-42
references: 18402983
references: Anal Biochem. 1971 Nov;44(1):276-87
references: 4943714
references: J Neurochem. 2000 Feb;74(2):785-91
references: 10646531
references: Gut. 1993 Feb;34(2):264-9
references: 8381760
references: Biochem Pharmacol. 1976 May 15;25(10):1201-3
references: 938542
references: Am J Physiol Gastrointest Liver Physiol. 2009 Aug;297(2):G406-17
references: 19477916
references: Stress. 2010 Jul;13(4):355-64
references: 20536337
references: Psychoneuroendocrinology. 2011 Apr;36(3):415-25
references: 20399565
references: J Affect Disord. 1996 Nov 4;41(1):39-53
references: 8938204
references: Eur J Pharmacol. 2009 Oct 12;620(1-3):49-56
references: 19699735
references: Life Sci. 1999;65(9):PL87-94
references: 10465356
references: Growth Horm IGF Res. 2009 Apr;19(2):136-45
references: 18809348
references: Neuropsychopharmacology. 2003 Sep;28(9):1579-88
references: 12784118
references: Neuropeptides. 1996 Oct;30(5):443-51
references: 8923506
references: Clin Nucl Med. 1998 Mar;23(3):163-4
references: 9509931
references: Regul Pept. 1992 Sep 3;41(1):39-47
references: 1360687
references: Physiol Behav. 2005 Apr 13;84(5):697-706
references: 15885245
references: J Psychosom Res. 2002 Oct;53(4):865-71
references: 12377295
references: Liver Int. 2005 Aug;25(4):808-16
references: 15998432
references: Neurosci Biobehav Rev. 1992 Winter;16(4):525-34
references: 1480349
references: Scand J Gastroenterol. 1996 Jul;31(7):678-81
references: 8819217
references: Dig Dis Sci. 1993 Feb;38(2):359-64
references: 8425449
references: Neuroscience. 2009 Apr 10;159(4):1233-43
references: 19409219
references: Nature. 1981 Nov 19;294(5838):259-60
references: 6117799
references: J Psychiatr Res. 2009 Jun;43(9):864-9
references: 19100996
references: Methods Enzymol. 1985;113:484-90
references: 3003504
references: Eur J Ophthalmol. 2002 Mar-Apr;12(2):77-83
references: 12022289
references: Anal Biochem. 1978 May;86(1):271-8
references: 655387
references: Neurochem Int. 2009 May-Jun;54(5-6):358-62
references: 19171172
references: Cell Mol Neurobiol. 2009 Jul;29(5):673-81
references: 19283469
references: Psychopharmacology (Berl). 1987;93(3):358-64
references: 3124165
references: Can J Physiol Pharmacol. 2009 Jun;87(6):440-7
references: 19526038
references: Am J Physiol Regul Integr Comp Physiol. 2003 Mar;284(3):R666-73
references: 12611391
references: Toxicol In Vitro. 2005 Aug;19(5):561-72
references: 15896549